Clinical Trial Update: Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

View source ↗

Summary

This study investigates mechanisms of primary resistance to first-line third-generation EGFR-TKIs in EGFR-mutant advanced non-small cell lung cancer. It include…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Lung Cancer, Non-small Cell, EGFR Gene Mutation | Status: RECRUITING